Northwest Biotherapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2021
May 18, 2021 at 02:46 am IST
Northwest Biotherapeutics, Inc. announced earnings results for the first quarter ended March 31, 2021. For the first quarter, the company announced total revenue was USD 239,000 compared to USD 570,000 a year ago. Operating loss was USD 19.570 million compared to USD 7.833 million a year ago. Net loss was USD 4.123 million compared to net income of USD 2.626 million a year ago.